26
Participants
Start Date
July 31, 2005
Primary Completion Date
June 30, 2008
Study Completion Date
October 31, 2008
VCL-IM01 (encoding IL-2) with Electroporation
IL-2-encoding plasmid formulated in phosphate-buffered saline at 0.5 mg/mL, 1.5 mg/mL, and 5.0 mg/mL (VCL-IM01) intratumorally injected and followed by electroporation with Inovio MedPulser® 1.0 cm array with needles up to 3 cm long (one 6-pulse cycle per tumor).
Location #2, Mobile
Location #1, Chicago
Location #3, Denver
Location #4, Montclair
Lead Sponsor
Vical
INDUSTRY